Pharma
Big Health CEO Peter Hames discusses how apps like his are changing therapy.
Also, Ujala Cygnus opens an ICU telemedicine facility in New Delhi.
THREAD Research CEO John Reites speaks on the state of remote and hybrid trials, and how COVID-19 has accelerated an already blossoming field.
Digital therapeutics startup Dthera Sciences was sunk by Alzheimer's drug failures, CMS reimbursemen
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer.
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.